TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17555378

Group type: COMPARATOR
Intervention: Caffeine 0 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine 75 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine 150 mg
Number of subjects: 20
Study: 15642723

Group type: EXPERIMENTAL
Intervention: Sequentially adjusted randomization procedure
Number of subjects: 200

Group type: COMPARATOR
Intervention: Efron's biased coin method
Number of subjects: 200
Study: 11925281

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0
Study: 10215943

Group type: EXPERIMENTAL
Intervention: FVIII/vWF concentrate (IMMUNATE [STIM plus])
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: FIX concentrate (IMMUNINE [STIM plus])
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (reconstituted concentrate incubated under the same conditions)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: High purity FIX concentrate
Number of subjects: 13
Study: 7529482

Group type: EXPERIMENTAL
Intervention: High-dose aprotinin (2 million IU before CPB, 500,000 IU/h until end of operation, 2 million IU added to the prime)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No aprotinin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 40
Study: 1706665

Group type: EXPERIMENTAL
Intervention: IVGG plus Aspirin (group G)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin alone (group A)
Number of subjects: 0
Study: 399320

Group type: EXPERIMENTAL
Intervention: Trazodone 50 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam 15 mg
Number of subjects: 0
Study: 30277193

Group type: EXPERIMENTAL
Intervention: Life review program
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study: 28749764

Group type: EXPERIMENTAL
Intervention: Household-based drinking water filter
Number of subjects: 189
Study: 25649680

Group type: EXPERIMENTAL
Intervention: Once-daily risperidone
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Once-daily olanzapine
Number of subjects: 680

Group type: COMPARATOR
Intervention: Twice-daily risperidone
Number of subjects: 680

Group type: COMPARATOR
Intervention: Twice-daily olanzapine
Number of subjects: 680
Study: 23598785

Group type: EXPERIMENTAL
Intervention: Oral probiotic (VSL3® Ferring), 2 tablets a day for 5 days, followed by 1 tablet daily for 10 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vaginal clindamycin 100 mg daily for 15 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oral probiotic (VSL3® Ferring)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vaginal clindamycin
Number of subjects: 40
Study: 21566302

Group type: EXPERIMENTAL
Intervention: Albumin alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Furosemide alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Albumin plus furosemide
Number of subjects: 10
Study: 18597165

Group type: EXPERIMENTAL
Intervention: Congruent expert evidence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incongruent expert evidence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Judicial instruction
Number of subjects: 0
Study: 16776048

Group type: EXPERIMENTAL
Intervention: Music therapy during surgery
Number of subjects: 150

Group type: COMPARATOR
Intervention: No music therapy during surgery (Control group)
Number of subjects: 150
Study: 14687016

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg bid)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Theophylline (250 mg bid)
Number of subjects: 10
Study: 11374407

Group type: EXPERIMENTAL
Intervention: Steroid-free immunosuppression with antithymocyte (ATG) induction for 10 days, followed by maintenance therapy with cyclosporine (CsA) and mycophenolate mofetil (MMF).
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Steroid-free immunosuppression protocol
Number of subjects: 100
Study: 9259427

Group type: EXPERIMENTAL
Intervention: Education (E)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Attention-Control (AC)
Number of subjects: 211
Study: 8299543

Group type: EXPERIMENTAL
Intervention: Nurse acting as case manager working in conjunction with family doctors and community agencies to implement a treatment plan for depression.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antidepressant medication (recommended introduction).
Number of subjects: 0
Study: 3102407

Group type: EXPERIMENTAL
Intervention: Diphosphonates (EHDP)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo or no drug therapy
Number of subjects: 177
Study: 29897397

Group type: EXPERIMENTAL
Intervention: Bayesian clustering analysis
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Genetic differentiation analysis
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Coalescent analyses
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Ecological niche modelling (ENM)
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: FST analysis
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Demographical scenario prediction
Number of subjects: 777
Study: 28830083

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 630

Group type: COMPARATOR
Intervention: Ramipril
Number of subjects: 630

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 630
Study: 23848141

Group type: EXPERIMENTAL
Intervention: Topical activated protein C (APC)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Physiological saline (placebo)
Number of subjects: 12
Study: 23688331

Group type: EXPERIMENTAL
Intervention: Simulation training for 45 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: No simulation training (Control)
Number of subjects: 0
Study: 20848591

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Number of subjects: 302
Study: 18279739

Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg/day for 4 weeks
Number of subjects: 20
Study: 17157119

Group type: EXPERIMENTAL
Intervention: L100/HCTZ12.5
Number of subjects: 292

Group type: COMPARATOR
Intervention: L100
Number of subjects: 292
Study: 12925319

Group type: EXPERIMENTAL
Intervention: Preventive antibiotic therapy (25 patients)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No preventive antibiotic therapy (24 patients)
Number of subjects: 49
Study: 10678603

Group type: EXPERIMENTAL
Intervention: Ultrasound therapy with neck-stretching exercises
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Trigger point injections with neck-stretching exercises
Number of subjects: 102

Group type: COMPARATOR
Intervention: Neck-stretching exercises only (Control)
Number of subjects: 102
Study: 9239167

Group type: EXPERIMENTAL
Intervention: Ice-bar cryotherapy (Elase)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No ice-bar cryotherapy
Number of subjects: 20
Study: 8461815

Group type: EXPERIMENTAL
Intervention: Prompted community care
Number of subjects: 181

Group type: COMPARATOR
Intervention: Hospital clinic care (control)
Number of subjects: 181
Study: 3491531

Group type: EXPERIMENTAL
Intervention: Supervised exercise training three times per week
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Supervised exercise training
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 30877850

Group type: EXPERIMENTAL
Intervention: Ongoing feedback condition (comprehension quiz and answers provided after each text segment)
Number of subjects: 148

Group type: COMPARATOR
Intervention: No-feedback condition (quiz and answers provided only at the end)
Number of subjects: 148
Study: 28108429

Group type: EXPERIMENTAL
Intervention: Telerehabilitation treatment options with feedback and monitoring technology (FMT), video communication, and flexible exercise hours.
Number of subjects: 104

Group type: COMPARATOR
Intervention: Home-based telerehabilitation scenarios with minimal physician supervision.
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional clinic-based rehabilitation.
Number of subjects: 104
Study: 26190629

Group type: EXPERIMENTAL
Intervention: Secure and optimal screw pathways (at least 7 mm in diameter)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: EP (entry point) measurements
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: AP (aiming point) measurements
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Influence of demographic and anatomic parameters
Number of subjects: 100
Study: 24176448

Group type: EXPERIMENTAL
Intervention: LVEDP > 22 mm Hg
Number of subjects: 1909

Group type: COMPARATOR
Intervention: LVEDP
Number of subjects: 1909
Study: 21873668

Group type: EXPERIMENTAL
Intervention: Lutein supplementation
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 19155155

Group type: EXPERIMENTAL
Intervention: Interactive patient-oriented group program
Number of subjects: 121

Group type: COMPARATOR
Intervention: Lecture-based information-only program
Number of subjects: 121
Study: 17450074

Group type: EXPERIMENTAL
Intervention: Plate-screw system (n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Double rod-screw system (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both systems (Plate-screw and Double rod-screw)
Number of subjects: 40
Study: 15125809

Group type: EXPERIMENTAL
Intervention: AR focus
Number of subjects: 455

Group type: COMPARATOR
Intervention: No AR focus (Control)
Number of subjects: 455
Study: 11417951

Group type: EXPERIMENTAL
Intervention: On-line HDF thrice weekly
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: On-line HDF twice weekly
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: On-line HDF once weekly
Number of subjects: 111

Group type: COMPARATOR
Intervention: High-flux HD
Number of subjects: 111
Study: 9659029

Group type: EXPERIMENTAL
Intervention: Ginger (2 g)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Droperidol (1.25 mg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ginger plus Droperidol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 7544967

Group type: EXPERIMENTAL
Intervention: 0.1% tretinoin cream
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 0.025% tretinoin cream
Number of subjects: 99

Group type: COMPARATOR
Intervention: vehicle
Number of subjects: 99
Study: 2660996

Group type: EXPERIMENTAL
Intervention: Intranasal salmon calcitonin (200 IU per day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 238046

Group type: EXPERIMENTAL
Intervention: co-trimoxazole
Number of subjects: 72

Group type: COMPARATOR
Intervention: chloramphenicol
Number of subjects: 72
Study: 30614328

Group type: EXPERIMENTAL
Intervention: Fast fetal growth trajectory
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Very-fast fetal growth trajectory
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Fastest growth trajectory
Number of subjects: 781

Group type: COMPARATOR
Intervention: Slow fetal growth trajectory
Number of subjects: 781
Study: 31291330

Group type: EXPERIMENTAL
Intervention: WAVES intervention (multi-faceted school-based obesity prevention intervention)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual activities (control group)
Number of subjects: 54
Study: 27932067

Group type: EXPERIMENTAL
Intervention: Nivolumab 1 mg/kg every 2 weeks plus ipilimumab 1 mg/kg every 12 weeks
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg every 2 weeks plus ipilimumab 1 mg/kg every 6 weeks
Number of subjects: 78
Study: 25987092

Group type: EXPERIMENTAL
Intervention: Home care service (nursing care service through hospital and home visits at 1st and 12th weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (monitored without intervention through hospital routine protocols at 1st and 12th weeks)
Number of subjects: 70
Study: 24099813

Group type: EXPERIMENTAL
Intervention: etoricoxib 120 mg oral once daily
Number of subjects: 56

Group type: COMPARATOR
Intervention: diclofenac 100 mg oral once daily
Number of subjects: 56
Study: 21636711

Group type: EXPERIMENTAL
Intervention: Postoperative systemic multiagent chemotherapy and intraventricular methotrexate (3 cycles, with possible additional 2 cycles if in complete remission)
Number of subjects: 45
Study: 19146568

Group type: EXPERIMENTAL
Intervention: TRIP intervention
Number of subjects: 0
Study: 17195765

Group type: EXPERIMENTAL
Intervention: 62% ethyl alcohol in emollient gel
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 0.1% benzalkonium chloride on a sanitary wipe
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 0.4% benzalkonium chloride on a sanitary wipe
Number of subjects: 39
Study: 15592697

Group type: EXPERIMENTAL
Intervention: High-dose-rate (HDR) brachytherapy
Number of subjects: 53

Group type: COMPARATOR
Intervention: Low-dose-rate (LDR) brachytherapy
Number of subjects: 53
Study: 11701296

Group type: EXPERIMENTAL
Intervention: computer‐generated telephone messages (autodialer)
Number of subjects: 3050

Group type: EXPERIMENTAL
Intervention: outreach worker
Number of subjects: 3050

Group type: EXPERIMENTAL
Intervention: autodialer with outreach worker backup
Number of subjects: 3050

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 3050
Study: 9162622

Group type: EXPERIMENTAL
Intervention: Inhalant glucocorticoid treatment (IGC)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Systemic glucocorticoid treatment (SGC)
Number of subjects: 161
Study: 7955291

Group type: EXPERIMENTAL
Intervention: HeartMate 1000 IP LVAD with no anticoagulants
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: HeartMate 1000 IP LVAD with heparin
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: HeartMate 1000 IP LVAD with low‐molecular‐weight dextran
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: HeartMate 1000 IP LVAD with dipyridamole plus aspirin
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: HeartMate 1000 IP LVAD with miscellaneous agents
Number of subjects: 57
Study: 3042938

Group type: EXPERIMENTAL
Intervention: Enteric-coated microsphere preparation (Pancrease)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional pancreatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pancrease (given for at least 3 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional pancreatin (given 10 months to 8 years earlier)
Number of subjects: 0
Study: 31800931

Group type: EXPERIMENTAL
Intervention: Text messaging (SMS) for six months
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 166
Study: 28418398

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 26508194

Group type: EXPERIMENTAL
Intervention: Multidisciplinary procedure combining 2.5% lidocaine and 2.5% prilocaine cream with preparation, education, positioning, and distraction
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Multidisciplinary procedure
Number of subjects: 132
Study: 22738166

Group type: EXPERIMENTAL
Intervention: Multizone refractive multifocal contact lenses
Number of subjects: 30
Study: 21943616

Group type: EXPERIMENTAL
Intervention: Direct Technique Myofascial Release (DT-MFR)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Indirect Technique Myofascial Release (IDT-MFR)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (slow soft stroking)
Number of subjects: 63
Study: 18082664

Group type: EXPERIMENTAL
Intervention: Low-dose estrogen for 7 days during the hormone-free interval
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 7 days during the hormone-free interval
Number of subjects: 0
Study: 17349080

Group type: EXPERIMENTAL
Intervention: SYN group received encapsulated bacteria (1 x 10(10) CFU of Lactobacillus rhamnosus GG and 1 x 10(10) CFU of Bifidobacterium lactis Bb12) and 10 g of inulin enriched with oligofructose
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: SYN treatment in cancer group
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group received encapsulated maltodextrin and 10 g of maltodextrin
Number of subjects: 74
Study: 15058367

Group type: EXPERIMENTAL
Intervention: experimental toothpaste formulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: whitening toothpaste product
Number of subjects: 24

Group type: COMPARATOR
Intervention: water
Number of subjects: 24
Study: 11316655

Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 11
Study: 9396883

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 4314

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 4314

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 4314

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure
Number of subjects: 4314

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure
Number of subjects: 4314

Group type: EXPERIMENTAL
Intervention: Clinical center
Number of subjects: 4314

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 4314

Group type: EXPERIMENTAL
Intervention: Non-white race (African-American and other)
Number of subjects: 4314

Group type: EXPERIMENTAL
Intervention: Abnormal glucose screen
Number of subjects: 4314
Study: 7911290

Group type: EXPERIMENTAL
Intervention: Foscarnet
Number of subjects: 9
Study: 3314317

Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 15

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 15
Study: 29962359

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 27283216

Group type: EXPERIMENTAL
Intervention: ARVUS technique
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard posterior reconstruction
Number of subjects: 66
Study: 26264399

Group type: EXPERIMENTAL
Intervention: Exenatide (twice daily)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Insulin glargine (daily)
Number of subjects: 46
Study: 24333184

Group type: EXPERIMENTAL
Intervention: Sofosbuvir (SOF) and Ribavirin (RBV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pegylated interferon (PegIFN) and Ribavirin (RBV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21059395

Group type: EXPERIMENTAL
Intervention: pCEsa1 DNA vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control fish
Number of subjects: 0
Study: 18637642

Group type: EXPERIMENTAL
Intervention: Citicoline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17706489

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.3 mg/kg bd for 5 days, 0.2 mg/kg bd for 5 days, 0.1 mg/kg bd for 5 days) + Ursodeoxycholic acid (5 mg/kg bd) + Phenobarbitone (5 mg/kg nocte)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Overall outcome
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Postoperative treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Surgical complications
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Perioperative complications
Number of subjects: 60
Study: 15379838

Group type: EXPERIMENTAL
Intervention: Psychological support counselling
Number of subjects: 66
Study: 11275389

Group type: EXPERIMENTAL
Intervention: Back pain
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Phantom limb pain
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: General pain
Number of subjects: 205
Study: 9715761

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms twice daily for 4 weeks)
Number of subjects: 11
Study: 7873290

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate 1000 micrograms/day (500 micrograms twice daily) as the sole corticosteroid therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group of voluntary healthy non-smoking women
Number of subjects: 38
Study: 3322749

Group type: EXPERIMENTAL
Intervention: Pterygium excision with Sr 90 irradiation
Number of subjects: 51

Group type: COMPARATOR
Intervention: Bare sclera technique alone (control)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: More complicated pterygium operations (including conjunctival flaps and keratoplasty)
Number of subjects: 51
Study: 31863563

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 1533

Group type: COMPARATOR
Intervention: Control (no aspirin)
Number of subjects: 1533
Study: 30125345

Group type: EXPERIMENTAL
Intervention: General anesthesia with PCA
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: General anesthesia with epidural
Number of subjects: 42

Group type: COMPARATOR
Intervention: Patients with preoperative insulin resistance (IR)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Patients with normal insulin sensitivity (IS)
Number of subjects: 42
Study: 28573681

Group type: EXPERIMENTAL
Intervention: Faster aspart
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin aspart
Number of subjects: 0
Study: 25761658

Group type: EXPERIMENTAL
Intervention: Functional beverage (FB) based on grape skin polyphenols, single-dose intake (187 mL)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Functional beverage (FB) based on grape skin polyphenols, sustained consumption (twice per day, 187 mL per day for 15 days)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Functional beverage (FB) based on grape skin polyphenols, both acute and sustained consumption
Number of subjects: 31
Study: 23481448

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of trivalent inactivated influenza vaccine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of trivalent inactivated influenza vaccine
Number of subjects: 22
Study: 21238826

Group type: EXPERIMENTAL
Intervention: Punch biopsy specimens
Number of subjects: 73
Study: 19473594

Group type: EXPERIMENTAL
Intervention: Deferasirox 20 mg/kg
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Deferasirox 40 mg/kg
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 182
Study: 17316692

Group type: EXPERIMENTAL
Intervention: Auditory feedback cue delivered through ear phones (device on)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Auditory feedback cue delivered through ear phones (residual effects)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 14
Study: 15054409

Group type: EXPERIMENTAL
Intervention: Prior exercise (cycling for 1 hour at 70-75% of maximal heart rate)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Rest (control)
Number of subjects: 9